首页> 外文期刊>Journal of Drug Delivery and Therapeutics >AN OVERVIEW OF VISCOSUPPLEMENTS: THERAPEUTIC MODALITY FOR THE AILMENT OF OSTEOARTHRITIS
【24h】

AN OVERVIEW OF VISCOSUPPLEMENTS: THERAPEUTIC MODALITY FOR THE AILMENT OF OSTEOARTHRITIS

机译:粘稠剂概述:骨关节炎病的治疗方法

获取原文
           

摘要

Osteoarthritis is a multifarious joint disease and is caused by inflammatory mediators, along with a procedure of wear and tear of cartilage. Osteoarthritis outcome in cartilage degradation, synovial inflammation, subchondral bone eburnation, degeneration of menisci, and capsular hypertrophy, which takes part in the pathogenesis of Osteoarthritis. Pain is the leading symptom of Osteoarthritis. However the precise mechanism causing pain is multifactorial and is still not well known. Viscosupplementation with intraarticular hylauronic acid promotes chondrocyte hyaluronic acid synthesis and prevents the additional cartilage degradation and may possible help to promote the cartilage regeneration. It is also postulated to diminish the production of inflammatory mediators and matrix metalloproteinase involved in Osteoarthritis. Viscosupplementation decline osteoarthritis symptoms in early to judicious Osteoarthritis, and improves functional outcome, if other conservative treatment modalities are ineffective. Hyaluronic acid (HA) is the major constituent of a 1-‐2μm layer on the surface of articular cartilage; it is also a major constituent of synovial fluid. HA has many properties including exerting an anti-inflammatory effect, it acts as a lubricant when movements in the joint are slow and as a shock absorber when movements are fast effect. Viscosupplementation relieves the symptoms of osteoarthritis of the knee, and this therapeutic effect may last several weeks. However, it is apparently not much greater than that of placebo and, according to some studies, it barely reaches clinical significance. Its pain-relieving effect seems comparable to that of other non-surgical options. The modest clinical benefit of viscosupplementation may never be great enough to outweigh its disadvantages, which include slow onset of action, the need for several weekly injections, the low but present risk of adverse reactions and the relatively high cost of this treatment. It helps in improving the function in early osteoarthritis knee joint and might delay the need for future knee surgery
机译:骨关节炎是多种多样的关节疾病,由炎症介质以及软骨的磨损过程引起。骨关节炎的结果是软骨退化,滑膜发炎,软骨下骨燃烧,半月板退化和荚膜肥大,这是骨关节炎的发病机理。疼痛是骨关节炎的主要症状。但是,引起疼痛的确切机制是多方面的,并且仍然未知。关节内透明质酸补充黏液可促进软骨细胞透明质酸的合成并防止额外的软骨降解,并可能有助于促进软骨再生。还假定其可减少涉及骨关节炎的炎症介质和基质金属蛋白酶的产生。如果其他保守治疗方法无效,那么粘液补充可以减轻骨关节炎早期至明智的骨关节炎症状,并改善功能预后。透明质酸(HA)是关节软骨表面1-2μm层的主要成分;它也是滑液的主要成分。 HA具有许多特性,包括发挥抗炎作用,在关节运动缓慢时,它可以起到润滑剂的作用;在运动效果快时,它可以起到减震器的作用。补充粘膜可缓解膝盖骨关节炎的症状,这种治疗效果可能持续数周。然而,它显然不比安慰剂大很多,并且根据一些研究,它几乎没有临床意义。它的止痛效果似乎与其他非手术疗法相当。增粘剂的适度临床益处可能永远不足以弥补其缺点,这些缺点包括起效缓慢,需要每周几次注射,不良反应风险低但目前存在,并且这种治疗的费用相对较高。它有助于改善早期骨关节炎的膝关节功能,并可能延迟将来膝关节手术的需要

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号